| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | 150-163 |
| Journal | Drug Resistance Updates |
| Volume | 14 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2011 |
Cite this
Shapira, A., Livney, Y. D., Broxterman, H. J., & Assaraf, Y. G. (2011). Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance. Drug Resistance Updates, 14(3), 150-163. https://doi.org/10.1016/j.drup.2011.01.003
@article{995cb07dec444010b77888385e4c9a2e,
title = "Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance",
author = "A. Shapira and Y.D. Livney and H.J. Broxterman and Y.G. Assaraf",
year = "2011",
doi = "10.1016/j.drup.2011.01.003",
language = "Undefined/Unknown",
volume = "14",
pages = "150--163",
journal = "Drug Resistance Updates",
issn = "1368-7646",
publisher = "Churchill Livingstone",
number = "3",
}
Shapira, A, Livney, YD, Broxterman, HJ & Assaraf, YG 2011, 'Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance' Drug Resistance Updates, vol. 14, no. 3, pp. 150-163. https://doi.org/10.1016/j.drup.2011.01.003
Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance. / Shapira, A.; Livney, Y.D.; Broxterman, H.J.; Assaraf, Y.G.
In: Drug Resistance Updates, Vol. 14, No. 3, 2011, p. 150-163.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
AU - Shapira, A.
AU - Livney, Y.D.
AU - Broxterman, H.J.
AU - Assaraf, Y.G.
PY - 2011
Y1 - 2011
U2 - 10.1016/j.drup.2011.01.003
DO - 10.1016/j.drup.2011.01.003
M3 - Article
VL - 14
SP - 150
EP - 163
JO - Drug Resistance Updates
JF - Drug Resistance Updates
SN - 1368-7646
IS - 3
ER -
Shapira A, Livney YD, Broxterman HJ, Assaraf YG. Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance. Drug Resistance Updates. 2011;14(3):150-163. https://doi.org/10.1016/j.drup.2011.01.003